Insider · CIK 0001808248
Firmani Lori
Reports to the SEC for 2 companies · COPENHAGEN N G7, G7
Transactions
15
Companies
2
Filings
5
CIK
0001808248
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-01-02 | DMRADamora Therapeutics, Inc.M Exercise/Conversion | — |
| 2026-01-02 | DMRADamora Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion | — |
| 2026-01-02 | DMRADamora Therapeutics, Inc.S Sale | −$2,890.35 |
| 2025-07-03 | DMRADamora Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion | — |
| 2025-07-03 | DMRADamora Therapeutics, Inc.M Exercise/Conversion | — |
| 2025-07-03 | DMRADamora Therapeutics, Inc.S Sale | −$498.33 |
| 2025-01-03 | DMRADamora Therapeutics, Inc.M Exercise/Conversion | — |
| 2025-01-03 | DMRADamora Therapeutics, Inc.S Sale | −$1,469.43 |
| 2025-01-03 | DMRADamora Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion | — |
| 2025-01-03 | DMRADamora Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2024-10-09 | DMRADamora Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2020-11-20 | F-star Therapeutics, Inc.S Sale | −$833 |
| 2020-11-19 | F-star Therapeutics, Inc.A Award | — |
| 2020-11-19 | F-star Therapeutics, Inc.Restricted Stock UnitsM Exercise/Conversion | — |
| 2020-11-19 | F-star Therapeutics, Inc.M Exercise/Conversion | — |
Recent filings
- 4Firmani Lori0001193125-26-004565SEC(opens sec.gov)
- 4Firmani Lori0000950170-25-094572SEC(opens sec.gov)
- 4Firmani Lori0000950170-25-002813SEC(opens sec.gov)
- 4Firmani Lori0000950170-24-114385SEC(opens sec.gov)
- 4Firmani Lori0000905718-20-001130SEC(opens sec.gov)
Companies
Address
OLE MAALOES VEJ 3 C/O GALECTO, INC.
COPENHAGEN N G7, G7, DK-2200